The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signalingInna Gordiienko, Sidorenko Sp|PLoS ONE|2017Cited by 24